What to Do About Obese Children?

By ACSH Staff — Oct 18, 2007
An October 18, 2007 item by blogger Elisa quotes Brain, Child magazine's Jennifer Niesslein quoting ACSH's Jeff Stier on HuffingtonPost.com about the downside of giving kids report cards for their weight:

An October 18, 2007 item by blogger Elisa quotes Brain, Child magazine's Jennifer Niesslein quoting ACSH's Jeff Stier on HuffingtonPost.com about the downside of giving kids report cards for their weight:

A Cancer Non-Epidemic

By ACSH Staff — Oct 17, 2007
This piece first appeared in the New York Post. We have an epidemic of disbelief about cancer in this country -- but it's the opposite of what you probably expect. Cancer death rates have been falling for years, and now are falling even faster. Yet it's still stories about allegedlyignored cancer threats that grab our attention.

This piece first appeared in the New York Post.
We have an epidemic of disbelief about cancer in this country -- but it's the opposite of what you probably expect. Cancer death rates have been falling for years, and now are falling even faster. Yet it's still stories about allegedlyignored cancer threats that grab our attention.

A Potential Breakthrough in Malaria Prevention

By ACSH Staff — Oct 17, 2007
Parents of infants in sub-Saharan Africa, where a million or more die each year, have new hope, thanks to a group of multinational researchers, led by Dr. John J. Aponte of the University of Barcelona and colleagues from Mozambique. They evaluated a new malaria vaccine's safety and efficacy in 214 infants in rural Mozambique, an area of high incidence of malaria, and found that the vaccine against Falciparum malaria, the most severe form, reduced the rate of new infections by almost two thirds.

Parents of infants in sub-Saharan Africa, where a million or more die each year, have new hope, thanks to a group of multinational researchers, led by Dr. John J. Aponte of the University of Barcelona and colleagues from Mozambique. They evaluated a new malaria vaccine's safety and efficacy in 214 infants in rural Mozambique, an area of high incidence of malaria, and found that the vaccine against Falciparum malaria, the most severe form, reduced the rate of new infections by almost two thirds.

Health Group Urges Reassessment of Asbestos as Human Health Risk

By ACSH Staff — Oct 15, 2007
Asbestos_cover New York, New York—October 15, 2007. Scientists and physicians associated with the American Council on Science and Health (ACSH) question whether typical asbestos exposures pose a substantial risk to human health.

Asbestos_cover New York, New York—October 15, 2007. Scientists and physicians associated with the American Council on Science and Health (ACSH) question whether typical asbestos exposures pose a substantial risk to human health.

Statin Helps Prevent Heart Attacks Long-Term

By ACSH Staff — Oct 15, 2007
A recent study in the New England Journal of Medicine shows that men who took Pravachol, a statin targeted at lowering cholesterol, for five years had lower incidence of heart attacks and death from heart disease ten years after cessation of treatment with the statin.

A recent study in the New England Journal of Medicine shows that men who took Pravachol, a statin targeted at lowering cholesterol, for five years had lower incidence of heart attacks and death from heart disease ten years after cessation of treatment with the statin.

Tobacco Harm Reduction Forum Provides Insight on Health-Related Issues of Both Cigarettes and Smokeless Tobacco Products

By ACSH Staff — Oct 09, 2007
An October 9, 2007 article by Becky Bell on the website of Southern Arkansas University describes a visit by ACSH's Jeff Stier to participate in a panel on smokeless tobacco as a means of harm reduction:

An October 9, 2007 article by Becky Bell on the website of Southern Arkansas University describes a visit by ACSH's Jeff Stier to participate in a panel on smokeless tobacco as a means of harm reduction:

Flu Vaccine Saves Lives: Learning Exactly How Many Can Wait

By ACSH Staff — Oct 03, 2007
There is an apparent discrepancy between last week's Lancet Infectious Diseases review article -- which asserted that the lifesaving benefits of influenza (flu) vaccination in the elderly was overstated -- and today's New England Journal of Medicine multicenter study of the extent of mortality benefit over a ten-year period -- which found that the death rate was substantially reduced among seniors who got the vaccine.

There is an apparent discrepancy between last week's Lancet Infectious Diseases review article -- which asserted that the lifesaving benefits of influenza (flu) vaccination in the elderly was overstated -- and today's New England Journal of Medicine multicenter study of the extent of mortality benefit over a ten-year period -- which found that the death rate was substantially reduced among seniors who got the vaccine.